![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Bioequivalence of Two Dosage Strength Fixed-Dose Combination
Formulations of Emtricitabine/Tenofovir Alafenamide (F/TAF) to
Elvitegravir/Cobicistat/Emtricitabine/TAF (E/C/F/TAF)
|
|
|
Reported by Jules Levin
8th IAS Conference on HIV Pathogenesis,
Treatment, and Prevention
Vancouver, British Columbia, Canada
19-22 July 2015
J Zack, S West, M Rhee, R Yu, A Vu, BP Kearney
Gilead Sciences, Foster City, California, USA
Pharmacokinetics of a Novel EVG/COBI/FTC/GS-7340 Single Tablet
Regimen.....http://www.natap.org/2012/pharm/Pharm_24.htm
13th HIV Clinical Pharmacology Workshop Apr 16-18 2012 Barcelona Spain
This study compares TAF 25 to TDF PK
http://www.natap.org/2015/EACS/EACS_57.htm
![HIV1](../images/092619/HIV1.gif)
![HIV2](../images/092619/HIV2.gif)
![HIV3](../images/092619/HIV3.gif)
![HIV4](../images/092619/HIV4.gif)
![HIV5](../images/092619/HIV5.gif)
![HIV6](../images/092619/HIV6.gif)
![HIV7](../images/092619/HIV7.gif)
![HIV8](../images/092619/HIV8.gif)
![HIV9](../images/092619/HIV9.gif)
![HIV10](../images/092619/HIV10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|